Haemodialysis in Type 1 and Type 2 Diabetic Patients with end Stage Renal Failure

  • Eberhard Ritz
  • Antony Raine
  • Daniel Cordonnier


In the early days of haemodialysis, efforts to treat and rehabilitate uremic diabetics were largely unsuccessful [1] until dialysis procedures and volume control had become more effective. Although diabetics have a poorer outcome than non-diabetics, survival on dialysis has improved to such an extent that today virtually no restrictions for admission to renal replacement therapy for these patients are justified. Consequently, diabetic nephropathy (assuming that in most cases renal failure is due to diabetic nephropathy) accounts for a large proportion of the dialysis population second only to glomerulonephritis and in some centers (as in Heidelberg) even exceeding glomerulonephritis [3].


Diabetic Patient Diabetic Nephropathy Renal Replacement Therapy Nephrol Dial Transplant Diabetic Polyneuropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ghavamian M, Gutch CG, Kopp KF, Kolff WJ. The sad truth about hemodialysis in diabetic nephropathy. JAMA 1972; 222: 1386–1389.PubMedCrossRefGoogle Scholar
  2. 2.
    Brunner FP, et al. Survival on renal replacement therapy: data from the EDTA registry. Nephrol Dial Transplant 1988; 1: 109–122.Google Scholar
  3. 3.
    Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of endstage renal failure from diabetic nephropathy type II — an epidemiological analysis. Nephrol Dial Transplant 1995; 10: 462–467.PubMedGoogle Scholar
  4. 4.
    Raine AEG. Epidemiology, development and treatment of end stage renal failure in non-insulin dependent diabetics in Europe. Diabetologia 1993; 36: 1099–1104.PubMedCrossRefGoogle Scholar
  5. 5.
    Cordonnier DJ, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J. Epidemiology, development and treatment of end-stage renal failure in Type 2 (non-insulin-dependent) diabetes. The case of mainland France and of overseas French territories. Diabetologia 1993; 36: 1109–1112.PubMedCrossRefGoogle Scholar
  6. 6.
    Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawtorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074–1079.PubMedCrossRefGoogle Scholar
  7. 7.
    Ritz E, Nowack R, Fliser D, Koch M, Tschöpe W. Type II diabetes: Is the renal risk adequately appreciated? Nephrol Dial Transplant 1991; 6: 679–682.PubMedCrossRefGoogle Scholar
  8. 8.
    Catalano C, Postorino M, Kelly PJ, Fabrizi F, Ennia G, Goodship TH. Diabetes mellitus and renal replacement therapy in Italy: prevalence, main characteristics and complications. Nephrol Dial Transplant 1990; 5: 788–796.PubMedCrossRefGoogle Scholar
  9. 9.
    Koch M, Tschöpe W, Ritz E. Ist die Betreuung niereninsuffizienter Diabetiker in der prädialytischen Phase verbesserungsbedürftig? (Must care for diabetics in the predialytic phase be improved?) Dtsch Med Wschr 1991; 116: 1543–1548.PubMedCrossRefGoogle Scholar
  10. 10.
    Parving HH. »The course of renal function before and during antihypertensive treatment in diabetic nephropathy.« In The Kidney and Hypertension in Diabetes Mellitus. 1.ed. Mogensen CE, ed. Boston: Martinus Nijhoff Publishing, 1988; pp 191–197.Google Scholar
  11. 11.
    Waldherr R, Ilkenhans C, Ritz E. How frequent is glomerulonephritis in diabetes mellitus type II? Clin Nephrol 1992; 37: 271–273.PubMedGoogle Scholar
  12. 12.
    Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E. Hypertension and cardiovascular risk factors in hemodialysed diabetic patients. Hypertension 1985; 7: 118–125.CrossRefGoogle Scholar
  13. 13.
    Koch M, Thomas B, Tschöpe W, Ritz E. Survival and predictors of death in dialysed diabetics. Diabetologia 1993; 36: 1113–1117.PubMedCrossRefGoogle Scholar
  14. 14.
    Tschöpe W, Koch M, Thomas B, Ritz E. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Nephrol 1992; 64: 354–358.Google Scholar
  15. 15.
    Majorca R, et al. A six year comparison of patient and technique survivals in CAPD and HD. Kidney Int 1988; 34: 518–524.CrossRefGoogle Scholar
  16. 16.
    United States Renal Data System. Annual Data Report. Am J Kidney Dis 1991; 18: Suppl. 2.Google Scholar
  17. 17.
    Kikkawa R, Arimura T, Haneda M, Nishio T, Katsunori S, Yagisawa M, Shigeta Y. Current status of Type 2 (non-insulin-dependent) diabetic subjects on dialysis therapy in Japan. Diabetologia 1993; 36: 1105–1108.PubMedCrossRefGoogle Scholar
  18. 18.
    Fujisawa T, Ikegami H, Shen GG. Angiotensin I-converting enzyme polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983–985.PubMedCrossRefGoogle Scholar
  19. 19.
    DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563–568.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Caro JF, Lanza-Jacoby S. Insulin resistance in uremia. J Clin Invest 1983; 72: 882.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Hörl WH, Haag-Weber M, Georgopoulos A, Block LH. The physicochemical characterization of a novel polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci 1990; 87: 6353–6357.PubMedCrossRefGoogle Scholar
  22. 22.
    Ritz E, Koch M. »Renal failure in diabetic nephropathy.« In Oxford Textbook in Clinical Nephrology. Cameron ST, Davison AM, Grünfeld JP, Kerr D, Ritz E, eds. Oxford Medical Publications, 1992; pp 1635-1655.Google Scholar
  23. 23.
    Ritz E, Fliser D, Siebels M. »Diabetic nephropathy.« In Textbook Clinical Nephrology. Massry SG, Glassock RJ, eds. Baltimore/London: Williams & Wilkins, 1994.Google Scholar
  24. 24.
    Grodstein G, Harrison A, Roberts C, Ippoliti A, Kopple JD. Impaired gastric emptying in hemodialysis patients. Kidney Int 1979; 16: 952 (a).Google Scholar
  25. 25.
    Weinrauch LA, D’Elia JA, Healy RW. Asymptomatic coronary artery disease angiography in diabetic patients before renal transplantation. Ann Intern Med 1978; 88: 346–348.PubMedCrossRefGoogle Scholar
  26. 26.
    Larsson O, Attman PO, Beckman-Suurkula M, Wallentin I, Wirkstrand J. Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile onset diabetes mellitus. Eur Heart J 1986; 7: 779–791.PubMedGoogle Scholar
  27. 27.
    Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993; 44: 617–621.PubMedCrossRefGoogle Scholar
  28. 28.
    Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998–1002.PubMedCrossRefGoogle Scholar
  29. 29.
    Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. Greater risk of cardiac events after coronary angioplasty (PTCA) than bypass grafting (CABG) in chronic dialysis patients. J Am Soc Nephrol 1992; 3: 389 (a).Google Scholar
  30. 30.
    Wizemann V, Kaufmann J, Kramer W. Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease. Nephron 1992; 62: 161–165.PubMedCrossRefGoogle Scholar
  31. 31.
    Uusitupa M, et al. Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed NIDDM (type II) and in non-diabetic subjects. Diabetes Res 1987; 4: 19–25.PubMedGoogle Scholar
  32. 32.
    Ritz E, Ruffmann K, Rambausek M, Mall G, Schmidli M. Dialysis hypotension — is it related to diastolic left ventricular malfunction? Nephrol Dial Transplant 1987; 2: 293–297.PubMedGoogle Scholar
  33. 33.
    Rischen-Vos J, van der Woude FJ, Tegzess AM, Zwinderman AH, Gooszen HC, van den Akker PJ, van Es LA. Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephrol Dial Transplant 1992; 7: 433–437.PubMedGoogle Scholar
  34. 34.
    Hirschl MM, Derfler K, Heinz G, Sunder-Plassmann G, Waldhäusl W. Long-term follow-up of renal transplantation in type 1 and type 2 diabetic patients. Clin Invest 1992; 70: 917–921.Google Scholar
  35. 35.
    Borgel F, Benhamou PY, Zmirou D, Balducci F, Halimi S, Cordonnier D. Assessment of handicap in chronic dialysis diabetic patients (Uremidiab Study). Scand J Rehab Med 1992; 24: 203–208.Google Scholar
  36. 36.
    Zmirou D, Benhamou PY, Cordonnier D, Borgel F, Balducci F, Papoz L, halimi S. Diabetes mellitus prevalence among dialysis patients in France (Uremidiab Study). Nephrol Dial Transplant 1992; 7: 1092–1097.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Eberhard Ritz
    • 1
    • 2
  • Antony Raine
    • 1
    • 2
  • Daniel Cordonnier
    • 1
    • 2
  1. 1.Klinikum der Universität HeidelbergMedizinische KlinikHeidelbergGermany
  2. 2.Centre Hospitalier Regional, et Universitaire de GrenobleGrenobleFrance

Personalised recommendations